AB Tylosoluble
- Description
Description
Composition :
Each 1 gm contains :
Tylosin tartrate 811.44mg
(Equiv. to tylosin base 750 mg)
Indications :
Treatment of respiratory disease caused by mycoplasma spp. :
1-CRD
2- Infectious synovitis
Dosage & Administration :
7 mg/10 liters orally via drinking water for 2-5 days.
Withdrawal Period:
1 day
Manufactured By:
Averroes Pharma